Can GLP-1 therapy worsen joint pain
New study on GLP-1 drugs and kids - GMA - 9/17/25 | Dr
doi: 10.1210/clinem/dgz069 130 FDA Briefing Document, Endocrinologic and Metabolic Drugs Advisory Committee Meeting (EMDA) (2017)
Its discovery traces back over 150 years to research on glucosuria ( By blocking sodium-glucose cotransporter 2 in the S1 and S2 segments of the proximal tubule, SGLT2i significantly reduce glucose reabsorption, promoting urinary glucose excretion
5-Amino-1MQ is a research compound investigated for its ability to inhibit nicotinamide N-methyltransferase (NNMT), an enzyme involved in regulating cellular metabolism, energy expenditure, and NAD+ (nicotinamide adenine dinucleotide) availability
It is believed to work by suppressing hunger so that you eat less, curbing cravings, and reducing the desire to snack